Tesla Patent with Indian Engineers Sparks H-1B Debate
A Tesla patent highlighting four Indian-origin engineers unexpectedly triggered a heated political debate about H-1B visas and immigrant contributions to American innovation.
Category : Search result: PAU patent
PAU Releases 2026 Kharif Kisan Melas Schedule
Punjab Agricultural University reveals dates for seven Kisan Melas in March 2026, urging farmers to participate for latest agricultural technologies.
Xreal Sues Viture Over Smart Glasses Patent Infringement
Chinese AR glasses maker Xreal files lawsuit against competitor Viture in Texas federal court, alleging patent infringement on key technologies ahead of Apple's expected market entry.
Pharma Q3 Preview: India Growth Offsets Revlimid Pain
Indian pharma companies face margin pressure from Revlimid patent expiry and US competition, but strong domestic sales and core business momentum may cushion the blow in Q3 FY26.
McConaughey Files Voice & Image with US Patent Office Against AI
Oscar-winning actor Matthew McConaughey has registered his voice and image with US patent authorities to prevent unauthorized AI use. His legal team explains this proactive move aims to protect his identity and capture value from new technology.
PAU Warns of Harsher Winter, Frost Threat to Punjab
Punjab Agricultural University climate expert Dr PK Khingra alerts farmers about severe cold wave, dense fog, and ground frost expected in coming days, advising protective measures for crops and livestock.
Patents Slow Innovation in Fast-Moving Tech Sectors
Patent laws designed for slower eras now hinder progress as AI accelerates discovery. Historical examples show how extended monopolies block innovation.
Delhi HC Allows Zydus to Sell Cheaper Cancer Drug Biosimilar
Delhi High Court overturns injunction, allowing Zydus Lifesciences to manufacture and sell biosimilar of Nivolumab, making cancer treatment 70% cheaper in India.
Delhi HC Permits Zydus to Sell Cancer Drug Biosimilar
Delhi High Court permits Zydus Lifesciences to sell its biosimilar of cancer drug Nivolumab until patent expiry in May 2026. Court mandates detailed sales records to protect innovator Squibb's interests. Read more.
US Professor Visits PAU for Joint Venture Talks
Dr. Rajinder S. Sidhu from California State University explores collaborative research and student exchange with Punjab Agricultural University in Ludhiana. Discover the future of Indo-US agricultural ties.
NSS Green Drive at PAU: 100 Saplings Planted
NSS volunteers from PAU, Ludhiana, planted 100 saplings in a major green drive. The initiative aims to combat pollution and promote environmental sustainability. Read more about this eco-effort.
25 Farmers Trained in Agribusiness at PAU Ludhiana
Punjab Agricultural University trains 25 farmers in entrepreneurship, focusing on value addition, marketing, and business skills to boost rural income and sustainability. Learn how this initiative transforms traditional farming.
Farmers Learn to Combat Pea & Potato Diseases
PAU scientists held a crucial workshop in Amritsar, empowering farmers with knowledge to manage pea and potato diseases. Learn the key strategies shared.
AI Tool Unlocks Patent Research, Saves R&D Time
Perplexity Patents, an AI-powered tool, helps innovation teams validate ideas and explore patent landscapes using natural language, preventing costly late-stage discoveries. Discover how it streamlines R&D.
MIMS Files 6 AI Medical Patents for Cancer Surgery
Mandya Institute of Medical Sciences announces 6 joint patent applications for AI-driven cancer detection tech, marking a major step in establishing a Medical AI & Robotics hub in Karnataka. Discover the breakthrough.
Natco Pharma Sues to Revoke Novo Nordisk's Semaglutide Patent
Natco Pharma files suit in Delhi High Court seeking revocation of Novo Nordisk's patent on diabetes drug semaglutide. Court issues notice, hearing set for Feb 5. Indian pharma race for generic Ozempic heats up.
KGMU-IIT Kanpur get patent for wearable breast sensor
SIB SHInE at KGMU, with IIT-Kanpur, patents a wearable sensor for early breast abnormality detection. A breakthrough in med-tech innovation. Read about the collaborative triumph.
PU's Robotic Lawn Mower Gets Patent for Grass Printing
Panjab University's Design Innovation Centre receives an Indian patent for its 'Grass Printer' robot. This autonomous machine can cut grass at varying heights to print messages, symbols, and intricate designs on large lawns, revolutionizing automated land
Why Indian Drug Makers Challenge Global Patents
Explore the high-stakes legal battles between Indian generic manufacturers and global pharma giants. Understand the impact on drug prices, accessibility, and the evolving IP landscape in India.
Natco Files to Revoke Novo Nordisk's Wegovy Patent in India
Hyderabad's Natco Pharma petitions Delhi High Court to revoke Novo Nordisk's semaglutide patent. The legal battle shapes India's future weight-loss drug market as 2026 patent expiry nears. Read more.
Ex-Minister Prabhu Lal Saini Patents 3 Date Palm Varieties
Former Rajasthan agriculture minister Prabhu Lal Saini secures patents for three indigenous date palm varieties, ST-1, ST-2, and ST-3, boosting local cultivation. Discover his 10-year research journey.
Ludhiana's 2026 Sports Infrastructure Push
Ludhiana residents and athletes demand upgraded sports facilities and better maintenance in 2026. Will the city's infrastructure meet growing public needs? Read more.
Extortionist Impersonates Ludhiana SHO, Uses Pakistani Number
A scammer impersonated Inspector Vijay Kumar, SHO of PAU police station, to extort money. The calls originated from a Pakistani number. Police urge public vigilance.
PAU Gets Patent for Rodent Contraceptive Bait
Punjab Agricultural University patents a groundbreaking contraceptive bait for rodents, offering a humane and effective solution to protect crops and public health. Learn about this innovative pest control method.
Generic Semaglutide to Create Rs 50,000 Cr Market
The patent expiry of semaglutide drugs will create a massive Rs 50 billion+ revenue opportunity for generic makers in India and globally over the next 12-15 months, boosting diabetes treatment access. Read the full analysis.
Generic Semaglutide to Create Rs 50bn+ Revenue Opportunity
Patent expiry of semaglutide drugs will create a Rs 50+ billion revenue chance for generic pharma firms in 12-15 months. Prices may drop up to 75%, boosting patient access. Read the full analysis.
Semaglutide Patent Expiry Creates Rs 50,000 Cr Opportunity
The patent expiry of Novo Nordisk's blockbuster drug semaglutide (Ozempic, Wegovy) opens a massive Rs 50,000+ crore market for Indian generic drugmakers, a new report reveals.
Why the Safety Pin Has a Hole: A 175-Year-Old Design Secret
Discover the engineering marvel behind the tiny hole in every safety pin. From Walter Hunt's 1849 patent to modern uses, learn how this simple feature ensures durability and function.
IIT Jodhpur files record 86 IPRs in 2025
IIT Jodhpur achieves a milestone with 86 IPR filings in 2025, marking a 150% growth. The patents focus on affordable, sustainable tech for national priorities. Discover the institute's innovation drive.
Indian Pharma Firms Eye Licensing Deals for Obesity Drugs
As patents expire, Indian drugmakers like Lupin and Ajanta Pharma are forging licensing and distribution deals for GLP-1 obesity drugs. The market is set for explosive growth. Explore the key partnerships and market dynamics.
Page 1 of 3